Investing in mRNA Technologies
David Maza, Managing Director and Head of Product at Direxion, joins Cheddar News to discuss the evolution of mRNA technologies, future applications of this tech including fighting Lyme disease and HIV, and what this all means for investors.
More Videos
$111 Billion Hollywood Merger: What Happens To Streaming, Studios And Talent?
Shirley Li, Staff Writer at The Atlantic, breaks down Paramount and WBD’s $111 billion merger and what it means for Hollywood, streaming and consumers.
Bitcoin’s Next Move: What Crypto Investors Need To Know Now
Tony Edward, author and host of the Thinking Crypto podcast, breaks down Bitcoin’s pullback, rate uncertainty, regulation and what could come next.
Job Seekers Are Losing Patience: How AI Is Changing The Hunt For Work
Matt Berndt, Lead Career Strategist at Indeed, explores AI’s impact on job hunting and why frustrated job seekers are feeling the fatigue.
Elon Musk’s $17 Billion AI Chip Bet: Inside The Terafab Plan
Barron’s Associate Editor Al Root breaks down Elon Musk’s Terafab plan, its massive scale and what it could mean for Tesla, SpaceX and xAI.
How To Shop Amazon Prime Day Like A Pro
Trae Bodge, shopping expert at TrueTrae.com, shares how to spot real Prime Day deals and when shoppers should buy Halloween and holiday items.
Inside The White House’s “Super Intelligence” AI Deal: What It Means For The Future Of Tech
Axios Tech Policy Reporter Maria Curi breaks down the White House’s “Super Intelligence” accord and what it means for AI safety and regulation.
